Crescent Diagnostics

Advanced warning for osteoporosis

Back read more

Reducing costs for healthcare providers

Osteoporosis is a serious condition that is frequently under diagnosed and consequently under treated.

It mainly affects postmenopausal women, but can also affect men. A typical manifestation of the disease is a hip fracture. Such breaks require hospitalisation and osteoporosis related hip fractures are a huge cost for healthcare providers.

There is currently no quick way to check for osteoporosis but Crescent’s pioneering Osentia screening test is about to change that.

Crescent Diagnostics has worked with BFG Healthcare to develop a consumer product that will allow consumers to have access to Crescent’s Bone Quality Test (BQT).

The consumer buys the kit at the local pharmacy and mails a nail clipping to the lab using the included vial and prepaid envelope. The lab inserts the clipping into a Raman spectrometer, where the sample is excited and produces a spectrum. Proprietary algorithms tag the sample according to the osteoporosis risk. A lab report is then sent back to the patient using a simple green-amber-red type of system - green means you’re fine; amber means you are at risk of osteoporosis and might consider making some lifestyle changes; red indicates that you could have a problem and should see your general practitioner.

Project Details

  • Client

    Crescent Diagnostics

  • Projects commissioned

    • Marketing strategy
    • Name Generation
    • Packaging design
    • Regulatory compliance
    • Website design
    • Exhibition design
  • Web Site

    www.osentia.co.uk